GL1X · GenesisL1 explorer

MolNFT v1 · #169450 · protein

Structure of the C. botulinum neurotoxin serotype a light chain protease in complex with covalent inhibitor 22

6XCD · Botulinum neurotoxin type a: “Structure of the C. botulinum neurotoxin serotype a light chain protease in complex with covalent inhibitor 22”. X-ray diffraction, 2 ligands (UZS, ZN), 5 pockets (best druggability 0.71). MolNFT v1…

PDB
6XCD
Type
protein
Length
423 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Botulinum neurotoxin type a
EC
3.4.24.69
UniProt
P0DPI0
Ligands
UZS, ZN
Pockets
5 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 31% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABotulinum neurotoxin type a (EC 3.4.24.69)protein42331% helix, 17% strandP0DPI0

Ligands and binding sites

  • UZS · N-hydroxy-7-sulfanylheptanamide · ligand · chains A
  • ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15420.710.8040ZN, UZS
2930.360.7520empty
3660.340.7713empty
4750.330.7516empty
5570.310.7613empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 6XCD · Structure of the C. botulinum neurotoxin serotype A light chain protease in complex with… · the same entry in another collection · chain A against A, TM-score 1.00
  • P0DPI0 · AlphaFold monomer V2.0 prediction for botulinum neurotoxin type a (P0DPI0) · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.